Clinical Trial: Necrotizing Enterocolitis (Nec) and B. Lactis in Premature Babies

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: Prevention of NEC in Preterm Infants With B. Lactis

Brief Summary: The purpose of the trial is to demonstrate the effect of B. lactis in reducing the incidence of Necrotizing Enterocolitis (NEC) compared to placebo in preterm infants.

Detailed Summary:
Sponsor: Nestlé

Current Primary Outcome: NEC onset [ Time Frame: 6 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Antibiotic administration and stool microbiology [ Time Frame: 6 weeks ]

Original Secondary Outcome: Same as current

Information By: Nestlé

Dates:
Date Received: September 15, 2009
Date Started: November 2009
Date Completion:
Last Updated: November 22, 2013
Last Verified: November 2013